Tofacitinib Solution
Product Images NDC 72205-121

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Tofacitinib (NDC 72205-121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tofacitinib-carton-label (Tofacitinib Carton Label)

Tofacitinib-carton-label (Tofacitinib Carton Label)
This text is a prescription drug label providing information about Tofacitinib Oral Solution, including dosage instructions, storage guidelines, and manufacturer details. The medication is stored in a specific temperature range with protections against light and requires using an oral dosing syringe for administration. The label also emphasizes the importance of not using the solution if the tamper-evident seal is broken, and to discard the solution after 60 days of opening. Additionally, it includes information on how to obtain and dispense the accompanying Medication Guide to each patient.*
FDA Label Image

Tofacitinib-cntr-label (Tofacitinib Cntr Label)

Tofacitinib-cntr-label (Tofacitinib Cntr Label)
This is a prescription medication called Tofacitinib Oral Solution with a concentration of 1 mg/mL, primarily used for medical purposes. It is important to dispense the accompanying Medication Guide with each patient. The solution should be stored between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C and 30°C (between 59°F and 86°F). It should be stored in the original bottle and carton to protect it from light. The oral dosing syringe and adapter are not made with natural rubber latex. The recommended dosage can be found in the Prescribing Information, and the Instructions for Use should be followed for correct use of the oral dosing syringe. Each 1 mL of oral solution contains 1 mg of tofacitinib (equivalent to 1.62 mg tofacitinib citrate). The contents of the bottle should be used within 60 days of opening, and any remaining oral solution should be discarded after 60 days. The medication is manufactured by MSN Pharmaceuticals Inc. and distributed by Novadoz Pharmaceuticals LLC. Contact information for Novadoz Pharmaceuticals is provided for further inquiries. This medication was issued in May 2026.*
FDA Label Image

Tofacitinib-figure-07 (Tofacitinib Figure 07)

FDA Label Image

Tofacitinib-figure-1 (Tofacitinib Figure 1)

FDA Label Image

Tofacitinib-figure-2 (Tofacitinib Figure 2)

FDA Label Image

Tofacitinib-figure-3 (Tofacitinib Figure 3)

Tofacitinib-figure-3 (Tofacitinib Figure 3)
This text is not readable.*
FDA Label Image

Tofacitinib-figure-5 (Tofacitinib Figure 5)

FDA Label Image

Tofacitinib-os-sy-adap (Tofacitinib Os Sy Adap)

Tofacitinib-os-sy-adap (Tofacitinib Os Sy Adap)
This text appears to be describing a press-in bottle adapter for dosing medication. It includes a syringe and a press-in plunger for oral dosing of Tolaciinib. The adapter likely helps in dispensing the medication accurately.*
FDA Label Image

Tofacitinib-step-1 (Tofacitinib Step 1)

FDA Label Image

Tofacitinib-step-10 (Tofacitinib Step 10)

FDA Label Image

Tofacitinib-step-11 (Tofacitinib Step 11)

Tofacitinib-step-11 (Tofacitinib Step 11)
Step 11. Clean oral dosing syringe*
FDA Label Image

Tofacitinib-step-2 (Tofacitinib Step 2)

FDA Label Image

Tofacitinib-step-3 (Tofacitinib Step 3)

FDA Label Image

Tofacitinib-step-4 (Tofacitinib Step 4)

Tofacitinib-step-4 (Tofacitinib Step 4)
This text appears to be instructions for a process involving the removal of air from an oral dosing syringe. Possibly part of a larger set of instructions for administering medication.*
FDA Label Image

Tofacitinib-step-5 (Tofacitinib Step 5)

FDA Label Image

Tofacitinib-step-6 (Tofacitinib Step 6)

FDA Label Image

Tofacitinib-step-7 (Tofacitinib Step 7)

Tofacitinib-step-7 (Tofacitinib Step 7)
The text provides a concise instruction regarding a step in a procedure, involving the removal of an oral dosing syringe. This might be part of a larger set of instructions or guidelines for administering medication.*
FDA Label Image

Tofacitinib-step-8 (Tofacitinib Step 8)

FDA Label Image

Tofacitinib-step-9 (Tofacitinib Step 9)

Tofacitinib-step-9 (Tofacitinib Step 9)
This is a guide to follow step 9, which instructs to take a dose of tofacitinib oral solution. Tofacitinib is a medication used to treat certain autoimmune diseases. It is important to follow specific instructions for the correct dosage and administration of this oral solution.*
FDA Label Image

Tofacitinib-structure (Tofacitinib Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.